MedTrace Logo

India PanOptix Post Marketing Study

NCT03706066 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2020-02-05

No results posted yet for this study

Summary

The purpose of this Post Marketing Study is to study the safety and effectiveness of the ACRYSOF IQ PanOptix intraocular lens (IOL) in an Indian population.

Conditions

  • Cataract

Interventions

DEVICE

Acrysof IQ PanOptix IOL

Single-piece, ultraviolet and blue-light filtering, foldable, multifocal intraocular lens (IOL) inserted into the capsular bag during cataract surgery

PROCEDURE

Cataract surgery

Per investigator's standard of care

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Study Director · Alcon Laboratories (India) PVT.LTD

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-15
Primary Completion
2020-01-18
Completion
2020-01-18
FDA Device
Yes

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03706066 on ClinicalTrials.gov